CANF
Can Fite Biopharma Ltd ADR
NYSE MKT: CANF · HEALTHCARE · BIOTECHNOLOGY
$3.10
+3.68% today
Updated 2026-04-30
Market cap
$6.23M
P/E ratio
—
P/S ratio
15.39x
EPS (TTM)
$-10.75
Dividend yield
—
52W range
$3 – $24
Volume
1.4M
Can Fite Biopharma Ltd ADR (CANF) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $745210.00 | $468996.00 | — | $1.78M | $0.00 | $164717.00 | $169500.00 | $844746.00 | $3.82M | $2.03M | $763000.00 | $853000.00 | $810000.00 | $743000.00 | $674000.00 | $408212.00 |
| Revenue growth (YoY) | — | -37.1% | -100.0% | — | -100.0% | — | +2.9% | +398.4% | +352.2% | -46.8% | -62.5% | +11.8% | -5.0% | -8.3% | -9.3% | -39.4% |
| Cost of revenue | — | $5.21M | — | $0.00 | $0.00 | $-282.00 | $-499.00 | $-2253.00 | $87000.00 | $51000.00 | — | — | — | $14999.00 | $7033.00 | $24190.00 |
| Gross profit | $745210.00 | $468996.00 | — | $1.78M | $0.00 | $164717.00 | $169500.00 | $844746.00 | $3.82M | $2.03M | $763000.00 | $853000.00 | $810000.00 | $743000.00 | $674000.00 | $384022.00 |
| Gross margin | 100.0% | 100.0% | — | 100.0% | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 94.1% |
| R&D | $2.82M | $3.41M | $3.52M | $4.42M | $4.16M | $3.86M | $6.08M | $5.27M | $6.08M | $10.98M | $11.95M | $9.85M | $7.76M | $5.98M | $5.76M | $6.75M |
| SG&A | — | — | $2.44M | $4.52M | $2.94M | $2.70M | $2.70M | $2.92M | $3.16M | $3.06M | $2.95M | $3.85M | $3.14M | $2.96M | $3.05M | $3.66M |
| Operating income | $-3.76M | $-4.78M | $-5.99M | $-8.99M | $-7.13M | $-6.42M | $-8.63M | $-7.38M | $-5.41M | $-12.01M | $-14.14M | $-12.84M | $-10.10M | $-8.20M | $-8.13M | $-10.03M |
| Operating margin | -505.1% | -1018.3% | — | -503.7% | — | -3894.6% | -5093.7% | -873.1% | -141.7% | -590.9% | -1853.1% | -1505.5% | -1246.4% | -1103.0% | -1206.2% | -2456.8% |
| EBITDA | $-3.53M | $-7.33M | $-5.98M | $-9.01M | $-7.12M | $-6.40M | $-8.68M | $-7.17M | $-6.13M | $-11.99M | $-14.13M | $-12.83M | $-10.08M | $-8.18M | $-8.12M | $-10.00M |
| EBITDA margin | -473.1% | -1563.5% | — | -504.9% | — | -3884.6% | -5119.2% | -848.3% | -160.4% | -590.2% | -1851.5% | -1503.9% | -1244.7% | -1100.9% | -1205.2% | -2450.9% |
| EBIT | $-3.60M | $-7.39M | $-6.01M | $-9.03M | $-7.13M | $-6.42M | $-8.70M | $-7.19M | $-6.14M | $-12.01M | $-14.14M | $-12.84M | $-10.10M | $-8.20M | $-8.13M | $-10.03M |
| Interest expense | $7328.00 | $377561.00 | $7227.00 | $16080.00 | $14894.00 | $564342.00 | $27296.00 | $1.10M | $1.20M | $427000.00 | $363000.00 | $227000.00 | $63000.00 | $14000.00 | $14000.00 | $14111.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-3.68M | $-6.70M | $-5.57M | $-8.34M | $-6.10M | $-4.80M | $-6.90M | $-4.97M | $-6.57M | $-12.63M | $-14.44M | $-12.60M | $-10.24M | $-7.63M | $-7.88M | $-9.91M |
| Net income growth (YoY) | — | -82.2% | +16.8% | -49.7% | +26.9% | +21.4% | -43.8% | +28.0% | -32.2% | -92.1% | -14.4% | +12.8% | +18.7% | +25.4% | -3.2% | -25.7% |
| Profit margin | -493.5% | -1428.5% | — | -467.3% | — | -2912.3% | -4069.3% | -588.2% | -172.0% | -621.3% | -1892.9% | -1476.6% | -1263.7% | -1027.5% | -1169.1% | -2426.7% |